Synthesis 1996; 1996(7): 843-846
DOI: 10.1055/s-1996-4314
paper
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Synthesis of 2-Chloro-2’-5’-dideoxy-5’-difluoromethylphosphinyladenosine: A Nonhydrolyzable Isosteric, Isopolar Analog of 2-Chlorodeoxyadenosine Monophosphate

Stuart G. Levy* , D. Bruce Wasson, Dennis A. Carson, Howard B. Cottam
  • *The Sam and Rose Stein Institute for Research on Aging, Department of Medicine 0663, University of California, San Diego, La Jolla, CA 92093, USA
Further Information

Publication History

Publication Date:
31 December 2000 (online)

2-Chloro-2’-5’-dideoxy-5’-difluoromethylphosphinyladenosine (5) was synthesized in thirteen steps from 3-O-benzyl-1,2-O-isopropylidene-D-ribofuranoside (1), a carbohydrate which is substituted differently at the 2- and 3-positions, making possible selective deprotection and reductive deoxygenation at the 2’-position of a nucleoside subsequent to glycosylation. Purine nucleoside phosphonate 5 is an analog of the monophosphate ester of the potent, clinically effective immunomodulatory agent 2-chlorodeoxyadenosine (2-CdA), and was synthesized to present a potential means of circumventing drug resistance in target immune cells.

    >